SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001356576-22-000010
Filing Date
2022-02-28
Accepted
2022-02-28 17:00:31
Documents
14
Period of Report
2022-02-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K supn-20220228.htm   iXBRL 8-K 49322
2 EX-99.1 ex99102-28x2022.htm EX-99.1 76777
6 supernuslogoa.jpg GRAPHIC 19991
  Complete submission text file 0001356576-22-000010.txt   304465

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20220228.xsd EX-101.SCH 1915
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT supn-20220228_lab.xml EX-101.LAB 24136
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20220228_pre.xml EX-101.PRE 12520
8 EXTRACTED XBRL INSTANCE DOCUMENT supn-20220228_htm.xml XML 10834
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35518 | Film No.: 22690933
SIC: 2834 Pharmaceutical Preparations